Arrowhead Pharmaceuticals... (ARWR)
18.46
0.41 (2.27%)
At close: Jan 15, 2025, 9:33 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 |
| Net Income | -609.69M | -209.28M | -176.49M | -140.85M | -84.55M | 67.97M | -54.45M | -34.38M | -81.72M | -91.94M | -58.63M | -31.14M | 80.00 | -8.79M | -6.20M | -19.31M | -27.09M | -29.93M | -19.00M | -6.62M | -2.50M | -95.24K | -246.21K | -185.82K | -137.55K | 593.00K | -51.62K | -854.53K |
| Depreciation & Amortization | 18.59M | 12.49M | 10.42M | 8.27M | 5.94M | 4.44M | 4.70M | 4.69M | 3.26M | 2.34M | 1.35M | 1.75M | 1.75M | 267.98K | 654.69K | 994.60K | 1.13M | 1.00M | 886.96K | 644.01K | 74.74K | 90.00 | 9.08K | 3.53K | 7.62K | 8.12K | 18.31K | 103.79K |
| Stock-Based Compensation | 73.97M | 78.13M | 120.89M | 76.67M | 43.38M | 12.39M | 8.45M | 7.89M | 11.60M | 10.23M | 5.70M | 1.54M | 1.24M | 1.38M | 1.58M | 2.68M | n/a | n/a | 1.37B | n/a | 142.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | 30.63M | -85.95M | -100.55M | 224.49M | -61.29M | 83.91M | -5.68M | -116.77K | 5.13M | 909.98K | 142.95M | 20.12M | -23.75K | -150.18K | -664.63K | 144.64K | -233.18K | 40.61K | 52.60K | 443.61K | 8.81M | -62.45K | 189.93K | 145.79K | 46.95K | 61.88K | -12.17K | 63.25K |
| Other Non-Cash Items | 29.19M | 16.31M | 7.34M | 266.00K | 525.30K | 1.07M | 383.07K | -43.52K | -5.63M | 13.14M | 3.07M | 990.27K | -17.97M | 193.88K | -2.72M | 2.53M | -1.40M | 5.02M | 3.60M | -3.56M | 65.71K | n/a | -51.55K | -51.61K | 816.00 | -700.57K | 98.00 | 667.25K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -432.14K | -890.36K | 2.35M | -2.89M | 8.09M | 7.69M | -576.27K | 1.55M | -13.54K | -1.35M | n/a | n/a | -1.37B | n/a | -142.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 25.09M | -51.55M | -98.29M | 226.87M | -60.69M | 87.16M | -5.88M | -1.21M | 5.72M | 3.41M | 5.00M | 140.01K | 216.09K | 6.90K | -996.35K | -824.86K | -233.18K | 40.61K | 1.36M | 443.61K | 42.07K | -62.45K | 182.85K | 152.09K | 49.03K | 64.23K | -12.94K | 88.06K |
| Operating Cash Flow | -462.85M | -153.89M | -136.13M | 171.22M | -95.39M | 173.03M | -47.22M | -23.94M | -64.43M | -65.71M | -35.42M | -19.03M | -15.34M | -5.39M | -7.70M | -15.28M | -27.58M | -23.87M | -14.79M | -9.10M | -2.31M | -157.60K | -105.83K | -81.81K | -80.09K | -35.22K | -46.15K | 4.56K |
| Capital Expenditures | -141.47M | -176.74M | -52.78M | -23.57M | -11.95M | -12.00M | -1.42M | -7.92M | -3.86M | -1.97M | -1.72M | -296.88K | -479.71K | -9.67K | -5.41K | -40.24K | -684.11K | -756.37K | -934.52K | -672.76K | -665.47K | -2.12K | -1.68K | n/a | -742 | n/a | n/a | n/a |
| Acquisitions | n/a | -80.58M | -47.36M | 141.68M | 240.78B | 47.75B | 7.43B | n/a | n/a | -10.00M | n/a | n/a | 121.03K | -1.70M | n/a | n/a | 109.38K | 5.14M | 205.07M | -8.00M | 305.84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -720.95M | -246.14M | -223.39M | -240.70M | -278.96M | -90.27M | -52.08M | -44.97M | n/a | n/a | -46.37M | -10.73M | n/a | 1.70B | n/a | n/a | n/a | n/a | -18.58M | 2.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 442.34M | 326.72M | 270.75M | 122.59M | 50.14M | 54.52M | 46.07M | 4.25M | 17.31M | 26.09M | 11.59M | 1.42M | 509.01K | 1.53M | n/a | 700.00K | n/a | n/a | 18.97M | 489.77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 80.58M | 47.36M | -141.68M | -240.78B | -47.75B | -7.43B | -40.73M | 17.31M | 500.00 | 10.00K | 89.50K | 290.31K | -1.70B | 493.00K | 79.38K | -2.00M | n/a | -205.07M | 8.03M | 305.84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -420.07M | -96.16M | -5.42M | -141.68M | -240.78M | -47.75M | -7.43M | -48.64M | 13.45M | 14.12M | -36.48M | -9.52M | 440.64K | -175.38K | 487.59K | 739.13K | -2.57M | 4.38M | -542.02K | 2.27M | -359.62K | -2.12K | -1.68K | n/a | -742 | n/a | n/a | n/a |
| Debt Repayment | 392.00M | n/a | n/a | n/a | n/a | -2.42M | -208.51K | -197.79K | -217.55K | -213.99K | -225.41K | -214.80K | -196.61K | n/a | n/a | 1.71M | -140.01K | n/a | n/a | n/a | n/a | n/a | 125.73K | 80.13K | -2.00K | -1K | -203 | -4.43K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 49.26M | 253.05M | 65.19M | 11.30M | 7.47M | 16.55M | 3.58M | -166.02K | 3.12M | 504.51K | 12.88M | 2.06M | 74.24K | n/a | -126.53K | 2.00M | n/a | n/a | n/a | n/a | n/a | 1.51M | n/a | n/a | 84.66K | 35.32K | 46.20K | n/a |
| Financial Cash Flow | 870.52M | 253.05M | 65.19M | 11.30M | 257.95M | 66.38M | 59.95M | 12.06M | 55.13M | 290.52K | 185.29M | 44.29M | 10.77M | 6.23M | 12.04M | 6.47M | 16.13M | 15.59M | 20.89M | 20.74M | 9.87M | 1.51M | 125.73K | 80.13K | 82.66K | 34.32K | 46.00K | -4.43K |
| Net Cash Flow | -8.21M | 2.89M | -76.43M | 40.85M | -78.22M | 191.67M | 5.29M | -60.53M | 4.15M | -51.30M | 113.40M | 15.74M | -4.13M | 660.23K | 4.83M | -8.07M | -14.03M | -3.90M | 5.55M | 13.91M | 5.84M | 1.36M | 18.22K | -1.68K | 1.83K | -894 | -147 | 131.00 |
| Free Cash Flow | -604.32M | -330.63M | -188.91M | 147.66M | -107.34M | 161.03M | -48.64M | -31.86M | -68.29M | -67.68M | -37.13M | -19.33M | -15.82M | -5.40M | -7.70M | -15.32M | -28.27M | -24.62M | -15.73M | -9.77M | -2.98M | -159.71K | -107.51K | -81.81K | -80.83K | -35.22K | -46.15K | 4.56K |